Johnson Craig A — SEC Form 4 filings
SEC reporting owner CIK 1370348. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-19 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. (MRTX) | Director | 1 | — | — | 8 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 4 | — | — | 7 |
| Aurinia Pharmaceuticals Inc. (AUPH) | Director | 4 | — | — | 5 |
Form 4 filings — Johnson Craig A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2025-11-24 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax withholding (F): 6,039 @ $15.68 | EDGAR |
| 2025-05-16 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 37,485 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2024-11-25 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 20,631 @ $0 · Grant/award (A): 31,688 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Mirati Therapeutics, Inc. (MRTX) | Disposition to issuer (D): 6,021 · Disposition to issuer (D): 4,444 · Disposition to issuer (D): 6,808 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1370348 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →